Birchview Capital, LP 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Birchview Capital, LP disclosed 69 US equity positions worth $132.4m in its Q3 2025 13F filing. The largest position was KLAC at 17.8% of the reported book, followed by BMY and CORT. Against the Q2 2025 filing, it opened 3 new positions, added to 15 and reduced 12 among the top 50 holdings.
What did Birchview Capital, LP own in Q3 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | KLAC KLA CORPORATION | Technology | 17.8% | $23.6m | 21,883 | 38% | added |
| 2 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 10.8% | $14.3m | 316,842 | -2% | reduced |
| 3 | CORT CORCEPT THERAPEUTICS INC | Healthcare | 4.2% | $5.6m | 67,200 | 0% | held |
| 4 | PROTHENA CORP PLC | 4.0% | $5.4m | 549,019 | 22% | added | |
| 5 | STOK STOKE THERAPEUTICS INC | Healthcare | 3.7% | $4.9m | 210,000 | 0% | held |
| 6 | QURE UNIQURE NV | 3.5% | $4.6m | 78,728 | -20% | reduced | |
| 7 | OVV OVINTIV INC | Energy | 3.3% | $4.3m | 107,500 | 0% | held |
| 8 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 3.0% | $4.0m | 28,690 | -7% | reduced |
| 9 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 2.8% | $3.6m | 171,000 | -9% | reduced |
| 10 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 2.4% | $3.2m | 48,000 | 0% | held |
| 11 | CMPX COMPASS THERAPEUTICS INC | 2.3% | $3.1m | 872,938 | – | new | |
| 12 | PHR PHREESIA INC | Healthcare | 2.0% | $2.7m | 114,700 | 0% | held |
| 13 | CSTL CASTLE BIOSCIENCES INC | Healthcare | 1.9% | $2.5m | 110,600 | 0% | held |
| 14 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 1.6% | $2.2m | 78,000 | 117% | added |
| 15 | BDSX BIODESIX INC | 1.6% | $2.2m | 286,804 | -95% | reduced | |
| 16 | QDELUSD QUIDELORTHO CORP | 1.6% | $2.1m | 72,548 | 0% | held | |
| 17 | AXGN AXOGEN INC | Healthcare | 1.6% | $2.1m | 119,078 | -26% | reduced |
| 18 | AM6 AMICUS THERAPEUTICS INC | 1.5% | $2.0m | 253,000 | 804% | added | |
| 19 | HROW HARROW HEALTH INC | 1.5% | $1.9m | 40,000 | -33% | reduced | |
| 20 | EQT EQT CORPORATION | Energy | 1.4% | $1.9m | 34,619 | 0% | held |
| 21 | SLDB SOLID BIOSCIENCES INC | Healthcare | 1.4% | $1.8m | 296,955 | 66% | added |
| 22 | OLMA OLEMA PHARMACEUTICALS INC | Healthcare | 1.3% | $1.7m | 174,000 | 30% | added |
| 23 | CYTK CYTOKINETICS INC | Healthcare | 1.2% | $1.6m | 30,000 | 200% | added |
| 24 | ALKS ALKERMES PLC | Healthcare | 1.1% | $1.5m | 50,000 | 0% | held |
| 25 | FHTX FOGHORN THERAPEUTICS INC | Healthcare | 1.0% | $1.4m | 281,730 | -9% | reduced |
| 26 | NVCR NOVOCURE LTD | Healthcare | 1.0% | $1.3m | 102,100 | 1% | added |
| 27 | UTHR UNITED THERAPEUTICS CORP | Healthcare | 0.9% | $1.3m | 3,000 | -29% | reduced |
| 28 | IMNM IMMUNOME INC | Healthcare | 0.9% | $1.2m | 105,000 | 75% | added |
| 29 | MASI* MASIMO CORP | 0.9% | $1.2m | 8,280 | 0% | held | |
| 30 | BCYC BICYCLE THERAPEUTICS PLC | Healthcare | 0.9% | $1.2m | 154,000 | – | new |
| 31 | TMCI TREACE MEDICAL CONCEPTS INC | Healthcare | 0.9% | $1.2m | 176,947 | 0% | held |
| 32 | KINIKSA PHARMACEUTICALS LTD | 0.9% | $1.2m | 30,000 | 0% | held | |
| 33 | OMGBP OUTSET MEDICAL INC | 0.8% | $1.1m | 78,584 | 127% | added | |
| 34 | INBX INHIBRX BIOSCIENCES INC | 0.8% | $1.1m | 31,698 | -1% | reduced | |
| 35 | DCGO DOCGO INC | 0.8% | $1.0m | 764,062 | 0% | held | |
| 36 | NTLA INTELLIA THERAPEUTICS INC | Healthcare | 0.8% | $1.0m | 60,000 | 0% | held |
| 37 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 0.8% | $1.0m | 43,060 | -58% | reduced |
| 38 | PHAT PHATHOM PHARMACEUTICALS INC | 0.8% | $1.0m | 85,000 | 240% | added | |
| 39 | SRRK SCHOLAR ROCK HOLDING CORP | Healthcare | 0.7% | $968.2k | 26,000 | 62% | added |
| 40 | XENE XENON PHARMACEUTICALS INC | Healthcare | 0.6% | $843.1k | 21,000 | 0% | held |
| 41 | 4XC1 KALVISTA PHARMACEUTICALS INC | 0.6% | $816.1k | 67,000 | 0% | held | |
| 42 | HALO HALOZYME THERAPEUTICS INC | Healthcare | 0.6% | $740.7k | 10,100 | 1% | added |
| 43 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 0.6% | $728.7k | 6,000 | 0% | held |
| 44 | FCX FREEPORT-MCMORAN CL-B | Basic Materials | 0.5% | $707.7k | 18,044 | 0% | held |
| 45 | RARE ULTRAGENYX PHARMACEUTICAL INC | Healthcare | 0.5% | $661.8k | 22,000 | 22% | added |
| 46 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC | Healthcare | 0.5% | $640.0k | 500,000 | 25% | added |
| 47 | APGE APOGEE THERAPEUTICS INC | Healthcare | 0.5% | $635.7k | 16,000 | 0% | held |
| 48 | ELUT ELUTIA INC | 0.5% | $633.1k | 711,175 | -39% | reduced | |
| 49 | VYGR VOYAGER THERAPEUTICS INC | Healthcare | 0.5% | $630.1k | 134,918 | – | new |
| 50 | ATEC ALPHATEC HOLDINGS INC | Healthcare | 0.4% | $479.8k | 33,000 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.